Literature DB >> 15349859

The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism.

Daniel G Healy1, Patrick M Abou-Sleiman, Kourosh R Ahmadi, Miratul M K Muqit, Kailash P Bhatia, Niall P Quinn, Andrew J Lees, David S Latchmann, David B Goldstein, Nicholas W Wood.   

Abstract

Mutations in the PINK1 gene (PARK6), a putative serine-threonine kinase, cause autosomal recessive Parkinson's disease. PINK1 functions as a protein kinase and confers protective effects in the mitochondria, where it is primarily located. We assessed in a population of European ancestry whether common genetic variation in this novel gene influences nonmendelian forms of Parkinson's disease. We defined the linkage disequilibrium structure of PINK1 and used this to identify a set of tagging single nucleotide polymorphisms that we estimate will efficiently represent all of the common DNA variation in the entire gene. Genotyping these tags in a set of 576 Parkinson's disease patients and 514 controls did not demonstrate a case-control partition for allele or for haplotype and thus provides evidence against the existence of a common functional variants in PINK1 that has a strong influence on PD risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15349859     DOI: 10.1002/ana.20206

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

Review 1.  Neurodegenerative disorders: Parkinson's disease and Huntington's disease.

Authors:  S M Hague; S Klaffke; O Bandmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

2.  Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.

Authors:  P A Broderick; L Wenning; Y-S Li
Journal:  J Neural Transm (Vienna)       Date:  2016-10-28       Impact factor: 3.575

Review 3.  Gene-environment interactions: key to unraveling the mystery of Parkinson's disease.

Authors:  Hui-Ming Gao; Jau-Shyong Hong
Journal:  Prog Neurobiol       Date:  2011-03-23       Impact factor: 11.685

Review 4.  Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance.

Authors:  Dena G Hernandez; Xylena Reed; Andrew B Singleton
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

5.  PINK1 mutation in Taiwanese early-onset parkinsonism : clinical, genetic, and dopamine transporter studies.

Authors:  Yi-Hsin Weng; Yah-Huei Wu Chou; Wen-Shiang Wu; Kun-Ju Lin; Hsiu-Chen Chang; Tzu-Chen Yen; Rou-Shayn Chen; Shiaw-Pyng Wey; Chin-Song Lu
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

6.  Txnip balances metabolic and growth signaling via PTEN disulfide reduction.

Authors:  Simon T Y Hui; Allen M Andres; Amber K Miller; Nathanael J Spann; Douglas W Potter; Noah M Post; Amelia Z Chen; Sowbarnika Sachithanantham; Dae Young Jung; Jason K Kim; Roger A Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-05       Impact factor: 11.205

7.  Genetic enhancement of cognition in a kindred with cone-rod dystrophy due to RIMS1 mutation.

Authors:  Sanjay M Sisodiya; Pamela J Thompson; Anna Need; Sarah E Harris; Michael E Weale; Susan E Wilkie; Michel Michaelides; Samantha L Free; Nicole Walley; Curtis Gumbs; Dianne Gerrelli; Piers Ruddle; Lawrence J Whalley; John M Starr; David M Hunt; David B Goldstein; Ian J Deary; Anthony T Moore
Journal:  J Med Genet       Date:  2007-01-19       Impact factor: 6.318

8.  Exclusion of PINK1 as candidate gene for the late-onset form of Parkinson's disease in two European populations.

Authors:  Anna Melissa Schlitter; Martin Kurz; Jan P Larsen; Dirk Woitalla; Thomas Mueller; Joerg T Epplen; Gabriele Dekomien
Journal:  J Negat Results Biomed       Date:  2005-12-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.